An eventful year – CEO Linda Persson summarises 2023!

Don’t miss the opportunity to see Linda Persson summarise 2023, an eventful year in which several significant milestones were achieved. “In summary, we have delivered as planned and strengthened our position as a company. We look forward to continuing our efforts to improve diagnostics for rectal cancer patients. Many thanks to my colleagues and to […]

Watch as CEO Linda Persson describes the path to the formal verification phase! (in Swedish)

Today, NanoEcho initiates the formal verification phase for its imaging system. This means that the integration and interaction processes have been completed, an internal evaluation of the system’s performance has been conducted, and documentation has been compiled. In the formal verification phase, NanoEcho’s imaging system will undergo controlled tests and evaluations, including those conducted by […]

NanoEcho at Medica!

Right now, NanoEcho is at the MEDICA fair in Düsseldorf, the world’s largest event for the medical industry. As a young and innovative company, we have secured a spot in the MEDICA START-UP PARK and have had fantastic meetings with distributors, surgeons, manufacturers, regulatory experts, and investors. “It’s amazing to experience such great interest in […]

Clinical Trials Nordics in Copenhagen

As part of the company’s increased clinical focus, NanoEcho, Ulrika Axelsson and Kristina Hallström participated in the 11th Annual Outsourcing in Clinical Trials Nordics 2023 in Copenhagen.

We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.